Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Rayzebio, Inc. (RYZB)  
$62.49 0.00 (0.00%) as of 4:30 Fri 2/23


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 60,790,000
Market Cap: 3.80(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.42 - $62.49
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,861,111 1,861,111
Total Buy Value $0 $0 $33,499,998 $33,499,998
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 2 2
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 18
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Shabet Rose Sharon   •       •       •   2024-02-26 4 D $0.00 $0 I/I (6,642,700) 0     -
   Kush Arvind CHIEF FINANCIAL OFFICER   •       –      –    2024-02-26 4 D $62.50 $4,902,063 D/D (78,433) 0     -
   Moran Susan CHIEF MEDICAL OFFICER   •       –      –    2024-02-26 4 D $62.50 $20,215,938 D/D (323,455) 0     -
   Katabi Maha   –       •      –    2024-02-26 4 D $62.50 $151,220,500 I/I (2,419,528) 0     -
   Song Kenneth PRESIDENT AND CHIEF EXECUTIVE   •       •      –    2024-02-26 4 D $62.50 $101,435,500 I/I (1,622,968) 0     -
   Heyman Richard A.   –       •      –    2024-02-26 4 D $62.50 $22,965,375 D/D (367,446) 0     -
   Moran Susan CHIEF MEDICAL OFFICER   •       –      –    2024-01-22 4 OE $3.24 $100,035 D/D 30,875 322,647     -
   Redmile Biopharma Investments Ii, L.p. 10% Owner   –       –       •   2023-09-19 4 A $0.00 $0 I/I 1,857,706 1,857,706     -
   Katabi Maha Director   –       •      –    2023-09-19 4 B $18.00 $8,499,996 I/I 472,222 1,209,764 2.1 182%     
   Katabi Maha Director   –       •      –    2023-09-19 4 A $0.00 $0 I/I 1,947,306 973,653     -
   Shabet Rose Sharon   •       •       •   2023-09-19 4 B $18.00 $25,000,002 I/I 1,388,889 1,743,556 0.01 182%     
   Shabet Rose Sharon   •       •       •   2023-09-19 4 A $0.00 $0 I/I 5,253,811 1,285,223     -
   Goodman Corey S   •       •       •   2023-09-19 4 A $0.00 $0 D/D 5,158,162 5,158,162     -
   Wellington Biomedical Innovation Master Investors   –       –       •   2023-09-19 4 A $0.00 $0 D/D 1,557,846 1,557,846     -
   Moran Susan Chief Medical OfficerOfficer   •       –      –    2023-09-14 3 IO $0.00 $0 D/D 0 291,772     -
   Song Kenneth President and Chief ExecutiveO   •       •      –    2023-09-14 3 IO $0.00 $0 I/I 0 1,622,095     -
   Heyman Richard A. Director   –       •      –    2023-09-14 3 IO $0.00 $0 D/D 0 367,446     -
   Kush Arvind Chief Financial OfficerOfficer   •       –      –    2023-09-14 3 IO $0.00 $0 D/D 0 77,557     -

  18 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed